// App-Quantinova.ai

: Comparison of piperacillin/tazobactam versus standard antibiotic regimens for the treatment of intrapartum clinical chorioamnionitis

Researchers

Presenter

  • Celeste Swain

Principal Investigators

  • Bruce Folck

  • Lue-Yen Tucker

  • Erin Niemasik

  • Mara Greenberg

Medical Centers

  • UC San Francisco, San Francisco, CA

  • Kaiser Permanente Northern California, Division of Research, Oakland, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Obstetrics/Gynecology

Disease

  • Clostridium difficile infection

  • Venous thrombosis

  • Postpartum hemorrhage

  • Chorioamnionitis

  • Endometritis

  • Sepsis

Biomarkers

  • N/A

Drug/Treatment

  • Piperacillin/tazobactam

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A